Resorbable lamellar particles of polylactide as adjuvants for influenza virus vaccines

被引:23
|
作者
Coombes, AGA
Major, D
Wood, JM
Hockley, DJ
Minor, PD
Davis, SS
机构
[1] Univ Nottingham, Dept Pharmaceut Sci, Nottingham NG7 2RD, England
[2] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England
基金
英国医学研究理事会;
关键词
polylactide; adjuvant; adsorption; influenza; vaccine;
D O I
10.1016/S0142-9612(98)00035-0
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Lamellar particles and microspheres were produced by precipitation from solutions of resorbable, biocompatible, semi-crystalline poly(L-lactide)[PLA] and amorphous poly(DL lactide co-glycolide)[PLG] copolymer, respectively, to investigate their adjuvanticity towards adsorbed influenza virus. Both types of substrate were capable of adsorbing large quantities of virus (>15% w/w) and retaining virus (> 60% of the initial load) over an 8 week time scale in-vitro. Potent immune responses were obtained in mice after the intra-muscular injection of adsorbed vaccine systems. The response to virus adsorbed on PLA lamellar particles was almost five times that obtained using PLG microspheres and fourteen times that using aqueous vaccine. The lamellar forms of PLA may function as an immunomodulator enhancing phagocytic activity due to their irregular shape and may be useful in improving the immune response to a variety of protein and viral antigens. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1073 / 1081
页数:9
相关论文
共 50 条
  • [31] Prevention of influenza virus infections by current inactivated influenza virus vaccines
    Couch, RB
    Keitel, WA
    Cate, TR
    Quarles, JA
    Taber, LA
    Glezen, WP
    OPTIONS FOR THE CONTROL OF INFLUENZA III, 1996, 1123 : 97 - 106
  • [32] Virus-like particles as vaccine adjuvants
    Gilbert, SC
    MOLECULAR BIOTECHNOLOGY, 2001, 19 (02) : 169 - 177
  • [33] Virus-like particles as vaccine adjuvants
    Sarah C. Gilbert
    Molecular Biotechnology, 2001, 19 : 169 - 177
  • [34] Inactivated influenza virus vaccines in children
    Ruben, FL
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (05) : 678 - 688
  • [35] Advances in the development of influenza virus vaccines
    Krammer, Florian
    Palese, Peter
    NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (04) : 294 - 294
  • [36] ATTENUATED INFLUENZA-VIRUS VACCINES
    POTTER, CW
    REVIEWS IN MEDICAL VIROLOGY, 1994, 4 (04) : 279 - 292
  • [37] Seasonal inactivated influenza virus vaccines
    Couch, Robert B.
    VACCINE, 2008, 26 : D5 - D9
  • [38] LIVE INFLUENZA-VIRUS VACCINES
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1974, 4 (5935): : 2 - 3
  • [39] Novel avian influenza virus vaccines
    Fuchs, W.
    Roemer-Oberdoerfer, A.
    Veits, J.
    Mettenleiter, T. C.
    REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES, 2009, 28 (01): : 319 - 332
  • [40] Advances in the development of influenza virus vaccines
    Florian Krammer
    Peter Palese
    Nature Reviews Drug Discovery, 2015, 14 : 167 - 182